Skip to main content
. Author manuscript; available in PMC: 2024 Sep 15.
Published in final edited form as: Neuroscience. 2023 Aug 9;528:102–116. doi: 10.1016/j.neuroscience.2023.07.031

Figure 2:

Figure 2:

Schematic of main vascular compartments, blood-brain barrier (BBB), and their potential changes in OUD. These changes can be caused directly by actions of self-administered mu-opioid receptor (MOP-r) agonists on immune cells and by neuroendocrine changes in the stress axis (e.g., affecting cortisol levels and its diverse downstream targets).